<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="publisher-id">PONE-D-10-02986</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0016323</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Anatomy and physiology</subject>
            <subj-group>
              <subject>Musculoskeletal system</subject>
              <subj-group>
                <subject>Muscle</subject>
                <subj-group>
                  <subject>Muscle functions</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Genetics</subject>
            <subj-group>
              <subject>Heredity</subject>
              <subj-group>
                <subject>Genotypes</subject>
                <subject>Phenotypes</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Human genetics</subject>
              <subj-group>
                <subject>Genetic association studies</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Anatomy and physiology</subject>
            <subj-group>
              <subject>Musculoskeletal system</subject>
              <subj-group>
                <subject>Muscle</subject>
                <subj-group>
                  <subject>Muscle functions</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Sports and exercise medicine</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Genetics and Genomics</subject>
          <subject>Physiology</subject>
        </subj-group>
      </article-categories><title-group><article-title>The K153R Polymorphism in the Myostatin Gene and Muscle Power Phenotypes in Young, Non-Athletic Men</article-title><alt-title alt-title-type="running-head">Myostatin K153R Polymorphism and Muscle Power</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
          <name name-style="western">
            <surname>Santiago</surname>
            <given-names>Catalina</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
          <name name-style="western">
            <surname>Ruiz</surname>
            <given-names>Jonatan R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Rodríguez-Romo</surname>
            <given-names>Gabriel</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Fiuza-Luces</surname>
            <given-names>Carmen</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Yvert</surname>
            <given-names>Thomas</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Gonzalez-Freire</surname>
            <given-names>Marta</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Gómez-Gallego</surname>
            <given-names>Félix</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Morán</surname>
            <given-names>María</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
          <xref ref-type="fn" rid="fn1">
            <sup>¶</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Lucia</surname>
            <given-names>Alejandro</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="fn" rid="fn1">
            <sup>¶</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Biomedicine, Universidad Europea de Madrid, Madrid, Spain</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Unit for Preventive Nutrition, Department of Biosciences and Nutrition at NOVUM, Karolinska Institutet, Stockholm, Sweden</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>INEF, Universidad Politécnica de Madrid, Madrid, Spain</addr-line>       </aff><aff id="aff4"><label>4</label><addr-line>Hospital Universitario 12 de Octubre, Madrid, Spain</addr-line>       </aff><contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Calbet</surname>
            <given-names>Jose A. L.</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group><aff id="edit1">University of Las Palmas de Gran Canaria, Spain</aff><author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">alejandro.lucia@uem.es</email></corresp>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: AL CS. Performed the experiments: CS GR-R CF-L TY MG-F FG-G. Analyzed the data: JRR. Contributed reagents/materials/analysis tools: AL. Wrote the paper: AL JRR MM. Conceived the project idea: AL MM. Provided statistical analysis: JRR.</p>
        </fn>
        <fn fn-type="other" id="fn1">
          <p>¶ These authors also contributed equally to this work.</p>
        </fn>
      <fn fn-type="conflict">
        <p>The authors have declared that no competing interests exist.</p>
      </fn></author-notes><pub-date pub-type="collection">
        <year>2011</year>
      </pub-date><pub-date pub-type="epub">
        <day>20</day>
        <month>1</month>
        <year>2011</year>
      </pub-date><volume>6</volume><issue>1</issue><elocation-id>e16323</elocation-id><history>
        <date date-type="received">
          <day>27</day>
          <month>9</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>12</month>
          <year>2010</year>
        </date>
      </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2011</copyright-year><copyright-holder>Santiago et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract>
        <p>The Lys(K)153Arg(R) polymorphism in exon 2 (rs1805086, 2379 A&gt;G replacement) of the myostatin (<italic>MSTN</italic>) gene is a candidate to influence skeletal muscle phenotypes. We examined the association between the <italic>MSTN</italic> K153R polymorphism and ‘explosive’ leg power, assessed during sprint (30 m) and stationary jumping tests [squat (SJ) and counter-movement jumps (CMJ)] in non-athletic young adults (University students) [n = 281 (214 men); age: 21–32 years]. We also genotyped the <italic>MSTN</italic> exonic variants E164K (rs35781413), I225T, and P198A, yet no subject carried any of these variant <italic>MSTN</italic> alleles. As for the K153R polymorphism, we found only one woman with the KR genotype; thus, we presented the results only for men. The results of a one-way ANCOVA (with age, weight and height entered as covariates) showed that men with the KR genotype (n = 15) had a worse performance in vertical jumps compared with those with the KK genotype [SJ: vertical displacement of center of gravity (CG) of 35.17±1.42 vs. 39.06±0.39 cm, respectively, P = 0.009; CMJ: vertical displacement of CG of 36.44±1.50 vs. 40.63±0.41 cm, respectively, P = 0.008]. The results persisted after adjusting for multiple comparisons according to Bonferroni. Performance in 30 m sprint tests did however not differ by K153R genotypes. In summary, the <italic>MSTN</italic> K153R polymorphism is associated with the ability to produce ‘peak’ power during muscle contractions, as assessed with vertical jump tests, in young non-athletic men. Although more research is still needed, this genetic variation is among the numerous candidates to explain, alone or in combination with other polymorphisms, individual variations in muscle phenotypes.</p>
      </abstract><funding-group><funding-statement>This study was funded by the Consejo Superior de Deportes (CSD, ref # UPR10/08), Fondo de Investigaciones Sanitarias (FIS, ref. # PS09/00194), and the Swedish Council for Working Life and Social Research (FAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts>
        <page-count count="5"/>
      </counts></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Some gene polymorphisms are candidates to explain individual variations in muscle phenotypes. The myostatin (<italic>MSTN</italic> or growth differentiation factor 8, <italic>GDF8</italic> [MIM601788]) gene <xref ref-type="bibr" rid="pone.0016323-Huygens1">[1]</xref> is receiving growing attention in the last years. The <italic>MSTN</italic> gene encodes myostatin, a skeletal muscle-specific secreted peptide that functions mainly to modulate myoblast proliferation and thus muscle mass and strength <xref ref-type="bibr" rid="pone.0016323-McPherron1">[2]</xref>. Variants of the <italic>MSTN</italic> gene are associated with muscle hypertrophy phenotypes in a range of mammalian species, most notably cattle <xref ref-type="bibr" rid="pone.0016323-McPherron2">[3]</xref>, <xref ref-type="bibr" rid="pone.0016323-Grobet1">[4]</xref>, dogs <xref ref-type="bibr" rid="pone.0016323-Mosher1">[5]</xref> and mice <xref ref-type="bibr" rid="pone.0016323-McPherron1">[2]</xref>. A <italic>MSTN</italic> polymorphism was recently associated with sprinting ability and racing stamina in thoroughbred horses <xref ref-type="bibr" rid="pone.0016323-Hill1">[6]</xref>. The myostatin-null mouse model also provides insights into the physiological role of this protein. Besides its function in reducing sarcopenia <xref ref-type="bibr" rid="pone.0016323-Siriett1">[7]</xref>, it appears that myostatin also regulates the structure and function of tendon tissues, as the stiffness of tendons is 14 times higher in myostatin-deficient mice than in their wild type controls <xref ref-type="bibr" rid="pone.0016323-Mendias1">[8]</xref>.</p>
      <p>Variations in the <italic>MSTN</italic> gene, as well as myostatin inhibition, can also have functional consequences in humans (see below). The potential association between <italic>MSTN</italic> variations and muscle mass phenotypes is best exemplified in the study by Schuelke <italic>et al</italic>. <xref ref-type="bibr" rid="pone.0016323-Schuelke1">[9]</xref>. They reported the case of 4-year old child with both copies of the <italic>MSTN</italic> gene carrying a mutation (g.IVS1+5g→a transition in the splice donor site in intron 1) that results in a premature stop codon and failure to synthesize a mature, functioning protein. The child exhibited extraordinary muscle development for his age and precocious physical prowess. Systemic treatment with the myostatin inhibitor MYO-029 provides an adequate safety margin and can induce improvements in the muscle strength/function of adult patients with muscular distrophies <xref ref-type="bibr" rid="pone.0016323-Wagner1">[10]</xref>. As this type of treatment would be likely to also stimulate muscle growth in healthy humans, myostatin manipulation could be among the next generation of doping in elite sports <xref ref-type="bibr" rid="pone.0016323-Fedoruk1">[11]</xref>.</p>
      <p>Of the identified <italic>MSTN</italic> variations in humans, the Lys(K)153Arg(R) polymorphism located in exon 2 (rs1805086, 2379 A&gt;G replacement) is one candidate to influence skeletal muscle phenotypes <xref ref-type="bibr" rid="pone.0016323-Ferrell1">[12]</xref>. The Lys(K)153Arg(R) aminoacid replacement is found within the active mature peptide of the myostatin protein; it could theoretically influence proteolytic processing with its propeptide, or affinity to bind with the extracellular activin type II receptor (ActRIIB). The latter results in intracellular activation the SMAD pathway, through which myostatin induces myoblast proliferation <xref ref-type="bibr" rid="pone.0016323-Thomas1">[13]</xref> and differentiation <xref ref-type="bibr" rid="pone.0016323-Rios1">[14]</xref>, and thus muscle mass <xref ref-type="bibr" rid="pone.0016323-Kostek1">[15]</xref>. The frequency of the mutant R allele is of about 3–4% among Caucasians, with a frequency of mutant homozygotes (RR) below 1% <xref ref-type="bibr" rid="pone.0016323-Ferrell1">[12]</xref>, <xref ref-type="bibr" rid="pone.0016323-Kostek1">[15]</xref>, <xref ref-type="bibr" rid="pone.0016323-Corsi1">[16]</xref>. Such low allelic frequency certainly limits the possibility of studying large groups of people carrying the R variant. To date, published data on the <italic>MSTN</italic> K153R polymorphism and human muscle phenotypes have yield controversial results, partly attributable to inter-ethnic and gender differences. Kostek et al. <xref ref-type="bibr" rid="pone.0016323-Kostek1">[15]</xref> recently found an association between the variant <italic>MSTN</italic> 153R allele and maximal isometric contraction of the elbow muscle flexors in African-American young adults of both genders, yet not in Caucasians. Previous studies reported no significant effect of <italic>MSTN</italic> variants on the muscle mass response to strength training of either Caucasians or African Americans of both genders, including World-class body-builders and elite power lifters <xref ref-type="bibr" rid="pone.0016323-Ferrell1">[12]</xref>. Although, in another study <italic>MSTN</italic> genotypes did not explain differences in the hypertrophic response to strength training in adults of both genders, when women were analysed separately, the 153R allele was associated with a greater muscle hypertrophic response to training <xref ref-type="bibr" rid="pone.0016323-Ivey1">[17]</xref>. The <italic>MSTN</italic> K153R polymorphism can also affect muscle phenotypes in the elderly <xref ref-type="bibr" rid="pone.0016323-Corsi1">[16]</xref>, <xref ref-type="bibr" rid="pone.0016323-Seibert1">[18]</xref>, <xref ref-type="bibr" rid="pone.0016323-GonzalezFreire1">[19]</xref>. For instance, Seibert et al. reported lower muscle strength in old African American women (n = 54, 70–79 years) who carried the variant 153R allele <xref ref-type="bibr" rid="pone.0016323-Seibert1">[18]</xref>.</p>
      <p>No study has yet assessed the association between <italic>MSTN</italic> genotypes and muscle power during naturally occurring movements, e.g. jumping and sprinting tasks. It was the purpose of our study to examine the association between the <italic>MSTN</italic> K153R polymorphism and ‘explosive’ leg power of non-athletic young adults, as assessed during specific jumping and sprint tests. We hypothesized that the 153R allele is associated with decreased performance in the aforementioned tests. We also genotyped the <italic>MSTN</italic> exonic variants E164K (rs35781413), I225T and P198A because they also seem to cause amino acid replacements in the gene product (myostatin) expressed in human skeletal muscle <xref ref-type="bibr" rid="pone.0016323-Saunders1">[20]</xref>.</p>
    </sec>
    <sec id="s2" sec-type="methods">
      <title>Methods</title>
      <sec id="s2a">
        <title>Ethics statement</title>
        <p>The Medical Ethics Committee of <italic>Universidad Europea de Madrid</italic> (Madrid, Spain) approved the study design, study protocols and informed consent procedure. All participants provided written informed consent.</p>
      </sec>
      <sec id="s2b">
        <title>Subjects</title>
        <p>The study sample comprised 281 healthy young adults (University students) [mean(SD) age: 21(2) years (range: 21, 32)] of both genders (214 men, 67 women) who took part in a previous study <xref ref-type="bibr" rid="pone.0016323-Santiago1">[21]</xref>. Inclusion criteria were to be free of any diagnosed cardiorespiratory disease, and not to be engaged in competitive sports such as (i) formal, supervised ‘power’ (e.g. weight lifting or alpine skiing) or jumping oriented type of training (e.g. plyometrics, volleyball or basketball) or (ii) endurance training (e.g. running, swimming of bicycling), that is, performing less than one (power) or three (endurance) structured weekly training sessions within the last year. All participants were of the same Spanish (Caucasian) ancestry for at least 3 generations.</p>
      </sec>
      <sec id="s2c">
        <title>Genotype assessment</title>
        <p>Sequences corresponding to the E164K, I225T, K153R and P198A variants were amplified during Spring 2009 by the polymerase chain reaction (PCR) in the Genetics Laboratory of the <italic>Universidad Europea de Madrid</italic>. The primers used were <named-content content-type="gene" xlink:type="simple">5′-GAAAACCCAAATGTTGCTTC-3′</named-content> and <named-content content-type="gene" xlink:type="simple">5′-TGTCTAGCTTATGAGCTTAGGG-3′</named-content>. The PCR conditions were as follows: initial denaturing at 95°C 10 min; 35 cycles at 95°C 1 min, 52°C 45 s, 72°C 1 min and a final extension at 72°C 5 min.</p>
        <p>The resulting PCR products were genotyped by single base extension (SBE) <xref ref-type="bibr" rid="pone.0016323-Juffer1">[22]</xref>. The primers used for E164K, I225T K153R, and P198A were <named-content content-type="gene" xlink:type="simple">5′-CAAACACTGTTGTAGGAGTCT-3′</named-content>, <named-content content-type="gene" xlink:type="simple">5′-CTGAATCCAACTTAGGCA-3′</named-content>, <named-content content-type="gene" xlink:type="simple">5′-TTTAATACAATACAATAAAGTAGTAA-3′</named-content>, and <named-content content-type="gene" xlink:type="simple">5′-TTTTTTTTATCTCTGAAACTTGACATGAAC-3′</named-content> respectively. The PCR SBE conditions were: 96°C 10 s; 25 cycles at 50°C 5 s and 60°C 30 s. The resulting PCR products were detected in an ABI PRISM (Applied Biosystems, Foster City, CA).</p>
      </sec>
      <sec id="s2d">
        <title>Phenotype assessment</title>
        <p>Assessment of leg muscle ‘explosive’ power was performed during spring 2008 in the same location (UEM) and all the tests were supervised by the same researchers, as detailed elsewhere <xref ref-type="bibr" rid="pone.0016323-Santiago1">[21]</xref>. Squat (SJ) and counter-movement jump (CMJ) tests were performed using an infrared contact timing platform (Globus Ergo Tester, Codognè, Italy) to evaluate leg muscles' ability to produce ‘explosive’ power <xref ref-type="bibr" rid="pone.0016323-Young1">[23]</xref>. Both tests were performed three times (each separated by a two-minute rest period) and the best score was retained.</p>
        <p>Subjects also performed a 30 m sprint test in an indoor rubberized track under two conditions: (1) starting from the stationary (standing) position <xref ref-type="bibr" rid="pone.0016323-Young1">[23]</xref> and (ii) starting with a previous 15 m run (running) thereby allowing achieving higher speeds in the first meters of the test <xref ref-type="bibr" rid="pone.0016323-Alcaraz1">[24]</xref>. The difference in performance time between both tests (at 15 m and 30 m respectively) was used as an index of subject's ability to produce acceleration, i.e. lesser difference implies higher acceleration capacity. We used photoelectric gates at 0, 15 and 30 meters to start and stop a digital timer. We previously showed the reliability of the aforementioned tests for explosive leg muscle power assessment in a subgroup of the present subjects <xref ref-type="bibr" rid="pone.0016323-Santiago1">[21]</xref>.</p>
      </sec>
      <sec id="s2e">
        <title>Statistical analysis</title>
        <p>We tested Hardy-Weinberg equilibrium using a χ<sup>2</sup> test. We analysed the differences in the study phenotypes among genotypes (KK vs. KR) of the K153R (rs1805086) polymorphism by one-way analysis of covariance, where the polymorphism was entered as a fixed factor, the phenotype was entered as a dependent variable, and age, weight and height were entered as covariates. We calculated the effect size statistics as Cohen's <italic>d</italic> (<italic>standardized mean differences</italic>) and 95% confidence interval <xref ref-type="bibr" rid="pone.0016323-Nakagawa1">[25]</xref>. Values of <italic>d</italic> 0.2, 0.5 and 0.8 are considered small, medium and large effects, respectively. We used Bonferroni &amp; Holm method to correct for multiple testing <xref ref-type="bibr" rid="pone.0016323-Holm1">[26]</xref>. All statistical analyses were performed using the PASW (v. 18.0 for WINDOWS, Chicago).</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <p>We detected no failures in sample collection and DNA acquisition. Genotyping success rate was &gt;99.29% (two missing data, one man and one woman).</p>
      <p>Genotype distributions met Hardy-Weinberg equilibrium (P = 0.59). No subject carried the variant alleles E164K, I225T, or P198A. We found only one woman with the KR genotype; thus, we present the results only for men. <xref ref-type="table" rid="pone-0016323-t001">Table 1</xref> shows the association between the K153R polymorphism and study phenotypes in men. We observed that men with the KR genotype had a worse performance in vertical jump (SJ and CMJ) compared with those with the KK genotype. The results persisted after adjusting for multiple comparisons. The variance explained ranged from 5 to 10%. Effect size statistics, as measured by the Cohen's <italic>d</italic>, indicated a medium effect size. Performance in sprint tests did not differ by K153R genotypes.</p>
      <table-wrap id="pone-0016323-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0016323.t001</object-id><label>Table 1</label><caption>
          <title>Mean estimates of study phenotypes by genotypes of the K153R (rs1805086) polymorphism in the <italic>GDF8</italic> gene in men.</title>
        </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pone-0016323-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0016323.t001" xlink:type="simple"/><table>
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="2" rowspan="1">KK (n = 201)</td>
              <td align="left" colspan="2" rowspan="1">KR (n = 15)</td>
              <td align="left" colspan="1" rowspan="1">P</td>
              <td align="left" colspan="1" rowspan="1">R<sup>2</sup></td>
              <td align="left" colspan="1" rowspan="1">Cohen's <italic>d</italic></td>
              <td align="left" colspan="1" rowspan="1">(95%CI)</td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" colspan="1" rowspan="1">
                <bold>Vertical Jump Tests</bold>
              </td>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">
                <bold>
                  <italic>SJ</italic>
                </bold>
              </td>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">Flight time (s)</td>
              <td align="left" colspan="1" rowspan="1">563.09</td>
              <td align="left" colspan="1" rowspan="1">(38.95)</td>
              <td align="left" colspan="1" rowspan="1">533.94</td>
              <td align="left" colspan="1" rowspan="1">(43.13)</td>
              <td align="left" colspan="1" rowspan="1">0.007</td>
              <td align="left" colspan="1" rowspan="1">0.100</td>
              <td align="left" colspan="1" rowspan="1">0.74</td>
              <td align="left" colspan="1" rowspan="1">0.461–1.014</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">Vertical displacement of CG (cm)</td>
              <td align="left" colspan="1" rowspan="1">39.06</td>
              <td align="left" colspan="1" rowspan="1">(5.44)</td>
              <td align="left" colspan="1" rowspan="1">35.17</td>
              <td align="left" colspan="1" rowspan="1">(5.49)</td>
              <td align="left" colspan="1" rowspan="1">0.009</td>
              <td align="left" colspan="1" rowspan="1">0.095</td>
              <td align="left" colspan="1" rowspan="1">0.71</td>
              <td align="left" colspan="1" rowspan="1">0.431–0.983</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">
                <bold>
                  <italic>CMJ</italic>
                </bold>
              </td>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">Flight time (s)</td>
              <td align="left" colspan="1" rowspan="1">574.35</td>
              <td align="left" colspan="1" rowspan="1">(39.62)</td>
              <td align="left" colspan="1" rowspan="1">543.29</td>
              <td align="left" colspan="1" rowspan="1">(46.20)</td>
              <td align="left" colspan="1" rowspan="1">0.005</td>
              <td align="left" colspan="1" rowspan="1">0.057</td>
              <td align="left" colspan="1" rowspan="1">0.76</td>
              <td align="left" colspan="1" rowspan="1">0.483–1.038</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">Vertical displacement of CG (cm)</td>
              <td align="left" colspan="1" rowspan="1">40.63</td>
              <td align="left" colspan="1" rowspan="1">(5.67)</td>
              <td align="left" colspan="1" rowspan="1">36.44</td>
              <td align="left" colspan="1" rowspan="1">(5.92)</td>
              <td align="left" colspan="1" rowspan="1">0.008</td>
              <td align="left" colspan="1" rowspan="1">0.053</td>
              <td align="left" colspan="1" rowspan="1">0.72</td>
              <td align="left" colspan="1" rowspan="1">0.446–0.999</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">
                <bold>Sprint Tests</bold>
              </td>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">
                <bold>
                  <italic>30m running start</italic>
                </bold>
              </td>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">Time at 15 m (s)</td>
              <td align="left" colspan="1" rowspan="1">1.92</td>
              <td align="left" colspan="1" rowspan="1">(0.14)</td>
              <td align="left" colspan="1" rowspan="1">1.91</td>
              <td align="left" colspan="1" rowspan="1">(0.08)</td>
              <td align="left" colspan="1" rowspan="1">0.684</td>
              <td align="left" colspan="1" rowspan="1">0.049</td>
              <td align="left" colspan="1" rowspan="1">0.11</td>
              <td align="left" colspan="1" rowspan="1">−0.159–0.378</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">Time at 30 m (s)</td>
              <td align="left" colspan="1" rowspan="1">3.76</td>
              <td align="left" colspan="1" rowspan="1">(0.21)</td>
              <td align="left" colspan="1" rowspan="1">3.75</td>
              <td align="left" colspan="1" rowspan="1">(0.17)</td>
              <td align="left" colspan="1" rowspan="1">0.987</td>
              <td align="left" colspan="1" rowspan="1">0.065</td>
              <td align="left" colspan="1" rowspan="1">0.00</td>
              <td align="left" colspan="1" rowspan="1">−0.263–0.273</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">
                <bold>
                  <italic>30m standing start</italic>
                </bold>
              </td>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">Time at 15 m (s)</td>
              <td align="left" colspan="1" rowspan="1">2.54</td>
              <td align="left" colspan="1" rowspan="1">(0.12)</td>
              <td align="left" colspan="1" rowspan="1">2.56</td>
              <td align="left" colspan="1" rowspan="1">(0.13)</td>
              <td align="left" colspan="1" rowspan="1">0.533</td>
              <td align="left" colspan="1" rowspan="1">0.002</td>
              <td align="left" colspan="1" rowspan="1">−0.17</td>
              <td align="left" colspan="1" rowspan="1">−0.436–0.101</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">Time at 30 m (s)</td>
              <td align="left" colspan="1" rowspan="1">4.41</td>
              <td align="left" colspan="1" rowspan="1">(0.19)</td>
              <td align="left" colspan="1" rowspan="1">4.44</td>
              <td align="left" colspan="1" rowspan="1">(0.23)</td>
              <td align="left" colspan="1" rowspan="1">0.559</td>
              <td align="left" colspan="1" rowspan="1">0.014</td>
              <td align="left" colspan="1" rowspan="1">0.16</td>
              <td align="left" colspan="1" rowspan="1">−0.111–0.425</td>
            </tr>
          </tbody>
        </table></alternatives><table-wrap-foot>
          <fn id="nt101">
            <label/>
            <p>Values are means (standard deviation).</p>
          </fn>
          <fn id="nt102">
            <label/>
            <p>P values related to group differences (one way analysis of covariance after adjusting for age, weight and height).</p>
          </fn>
          <fn id="nt103">
            <label/>
            <p>Cohen's <italic>d</italic> (standardized mean differences) and 95% confidence interval (CI). Values of d 0.2, 0.5 and 0.8 are considered small, medium and large effects, respectively.</p>
          </fn>
          <fn id="nt104">
            <label/>
            <p>Abbreviations: SJ, squat jump; CMJ, counter-movement jump; CG, centre of gravity.</p>
          </fn>
        </table-wrap-foot></table-wrap>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>The main, novel finding of our study was that the variant 153R allele of the <italic>MSTN</italic> K153R polymorphism is associated with decreased jumping performance in young non-athletic men. Sprinting (running) ability was however unaffected by the <italic>MSTN</italic> K153R genotypes. Although more research is needed, and while keeping in mind that exercise-related phenotypes are likely polygenic, our data give support for a role of the <italic>MSTN</italic> K153R polymorphism in explaining, at least partly, individual variations in the humans' capacity for muscle ‘peak’ power generation. In contrast, in the present cohort of subjects we previously found no association between performance in the jump/sprint tests and the R577X polymorphism in the gene (<italic>ACTN3</italic>) encoding α-actinin-3 <xref ref-type="bibr" rid="pone.0016323-Santiago1">[21]</xref>. This variation is thought to play an important role in the muscles' ability to produce high power, at least in elite athletes <xref ref-type="bibr" rid="pone.0016323-Yang1">[27]</xref>.</p>
      <p>We assessed ‘explosive’ muscle power by means of jumping and sprinting tests, which are naturally occurring multi-joint movements in humans that involve the coordinated participation of the majority of lower limb muscles <xref ref-type="bibr" rid="pone.0016323-Ashley1">[28]</xref>, <xref ref-type="bibr" rid="pone.0016323-Brown1">[29]</xref>. We believe this is in fact a strength of our study versus previous research in the field of genetics and exercise-related phenotypes that used other tests for muscle power assessment, for instance, maximal concentric muscle work during single-joint movements (e.g. flexor elbow contractions) at relatively low angular velocities (≤120°·s<sup>−1</sup>) <xref ref-type="bibr" rid="pone.0016323-Thomis1">[30]</xref>. However, during actual natural high muscle power actions such as the sprint and jumps performed by our subjects, angular velocities at the hip or knee joints can approach 800–1000°·s<sup>−1</sup> <xref ref-type="bibr" rid="pone.0016323-Bosco1">[31]</xref>. To note is that our findings are partly limited by the fact that we did not assess muscle mass in our cohort, and therefore we could not determine whether the influence of <italic>MSTN</italic> K153R genotypes on muscle power is mediated by its expected effects on muscle mass. Finally, the finding that the <italic>MSTN</italic> K153R polymorphism was associated with vertical jump performance but not with sprint performance warrants further investigation. Although both tests are thought to determine muscle power performance, stationary jumps and running sprints are determined by different factors. The critical factor during running sprints, owing to the short duration of the foot contact on the ground, is the rate of force development, which in turn is determined by many factors such as muscle fibre type, synchronization of motor units, tendon stiffness, or lean mass of lower extremities <xref ref-type="bibr" rid="pone.0016323-PerezGomez1">[32]</xref>. In contrast, the ability of leg muscles (quadriceps) to produce power during the concentric phase of muscle contraction is the main factor affecting stationary vertical jumps as the ones we used here <xref ref-type="bibr" rid="pone.0016323-Ham1">[33]</xref>. The elastic properties of tendons can also influence jump ability, at least in the case of CMJ. Compared with a stiffer muscle tendon complex (MTC), people with a more compliant MTC should be more efficient in utilizing elastic strain energy during jumps <xref ref-type="bibr" rid="pone.0016323-Kubo1">[34]</xref>, <xref ref-type="bibr" rid="pone.0016323-Cavagna1">[35]</xref>. The fact that our KR subjects showed worst jumping performance than their wild-type KK counterparts could be associated, at least partly, with a potential role of myostatin in tendon structure. Myostatin-deficient mice showed indeed 14 times higher tendon stiffness than wild-type mice <xref ref-type="bibr" rid="pone.0016323-Mendias1">[8]</xref>. Further research is needed to determine the possible association between <italic>MSTN</italic> polymorphisms and tendon characteristics in humans. Up to date, published data on the <italic>MSTN</italic> K153R polymorphism and human muscle phenotypes (at baseline or in response to training) have yield controversial results, at least in adults of young or medium age. Inter-ethnic differences in allele frequencies, gender-related differences and the low allelic frequency of the 153R allele (limiting the possibility of studying large groups of people carrying the R variant) are important reasons for controversy. Kostek et al. <xref ref-type="bibr" rid="pone.0016323-Kostek1">[15]</xref> recently found an association between the <italic>MSTN</italic> 153R allele and maximal isometric contraction of the elbow muscle flexors in a group of 23 African-American young adults of both genders, yet this association was not corroborated in a much larger cohort of Caucasian young adults (n = 509, also men and women). Maximal dynamic contraction (one repetition maximum) was also unaffected by <italic>MSTN</italic> genotypes in both cohorts. Ferrell et al. <xref ref-type="bibr" rid="pone.0016323-Ferrell1">[12]</xref> reported no significant effect of the <italic>MSTN</italic> variants we studied here on the muscle mass response to strength training in either Caucasians or African Americans (n = 153 men and women). In another study <xref ref-type="bibr" rid="pone.0016323-Ivey1">[17]</xref>, <italic>MSTN</italic> genotypes did not explain differences in the hypertrophic response to strength training in 32 adults (age range: 21–75 years) of both genders studied as a group; yet, when women were analyzed separately the 153R allele was associated with a 68% larger increase in muscle volume in response to training. Thomis et al. <xref ref-type="bibr" rid="pone.0016323-Thomis1">[30]</xref> reported similar values in elbow flexor strength at baseline or in response to training in a young adult with the 153KR genotype compared with those with the 153KK genotype. Evidence for the putative influence of the <italic>MSTN</italic> K153R polymorphism on muscle phenotypes is probably stronger in the elderly <xref ref-type="bibr" rid="pone.0016323-Corsi1">[16]</xref>, <xref ref-type="bibr" rid="pone.0016323-Seibert1">[18]</xref>, <xref ref-type="bibr" rid="pone.0016323-GonzalezFreire1">[19]</xref>. Notably, in a cohort of old African American women (n = 54, 70–79 years). Seibert et al. <xref ref-type="bibr" rid="pone.0016323-Seibert1">[18]</xref> reported lower muscle strength (hip and knee flexion and handgrip strength combined) in those who carried the 153R allele. We recently reported lower muscle mass/function in a very old woman (age 96 years) with the very rare <italic>MSTN</italic> 153RR genotype compared to her age-matched referents with the 153KK genotype <xref ref-type="bibr" rid="pone.0016323-GonzalezFreire1">[19]</xref>.</p>
      <p>Although more research is needed, the putative effect of the K153R polymorphism on muscle phenotypes is due to its potential to alter the function of the <italic>MSTN</italic> gene <xref ref-type="bibr" rid="pone.0016323-Ferrell1">[12]</xref>. Myostatin enters the bloodstream as a latent precursor protein; it then undergoes a proteolytic process to become a mature peptide (free from the propeptide) that binds to extracellular activin type II receptor (ActRIIB) <xref ref-type="bibr" rid="pone.0016323-Kostek1">[15]</xref>. Binding of myostatin to ActRIIB induces intracellular activation of SMAD proteins and, through the SMAD pathway, myostatin modulates myoblast proliferation <xref ref-type="bibr" rid="pone.0016323-Thomas1">[13]</xref> and differentiation <xref ref-type="bibr" rid="pone.0016323-Rios1">[14]</xref>, and thus ultimately muscle mass <xref ref-type="bibr" rid="pone.0016323-Kostek1">[15]</xref>. The Lys(K)153Arg(R) aminoacid replacement is found within the active mature peptide of the myostatin protein, and could theoretically influence (i) proteolytic processing with its propeptide or (ii) affinity to bind with ActRIIB <xref ref-type="bibr" rid="pone.0016323-Lee1">[36]</xref>, <xref ref-type="bibr" rid="pone.0016323-Jiang1">[37]</xref>. This in turn would result in inability of myostatin to modulate muscle mass/power <xref ref-type="bibr" rid="pone.0016323-Kostek1">[15]</xref>.</p>
      <p>In summary, the <italic>MSTN</italic> K153R polymorphism is associated with the ability to produce ‘peak’ power during muscle contractions, as assessed with vertical jump tests, in young non-athletic men. Thus, although more research is still needed, this polymorphism is among the numerous candidates to explain, alone or in combination with other polymorphisms, individual variations in muscle phenotypes.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pone.0016323-Huygens1">
        <label>1</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Huygens</surname><given-names>W</given-names></name><name name-style="western"><surname>Thomis</surname><given-names>MA</given-names></name><name name-style="western"><surname>Peeters</surname><given-names>MW</given-names></name><name name-style="western"><surname>Aerssens</surname><given-names>J</given-names></name><name name-style="western"><surname>Janssen</surname><given-names>R</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Linkage of myostatin pathway genes with knee strength in humans.</article-title>             <source>Physiol Genomics</source>             <volume>17</volume>             <fpage>264</fpage>             <lpage>270</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-McPherron1">
        <label>2</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>McPherron</surname><given-names>AC</given-names></name><name name-style="western"><surname>Lawler</surname><given-names>AM</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SJ</given-names></name></person-group>             <year>1997</year>             <article-title>Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member.</article-title>             <source>Nature</source>             <volume>387</volume>             <fpage>83</fpage>             <lpage>90</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-McPherron2">
        <label>3</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>McPherron</surname><given-names>AC</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SJ</given-names></name></person-group>             <year>1997</year>             <article-title>Double muscling in cattle due to mutations in the myostatin gene.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>94</volume>             <fpage>12457</fpage>             <lpage>12461</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Grobet1">
        <label>4</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Grobet</surname><given-names>L</given-names></name><name name-style="western"><surname>Martin</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Poncelet</surname><given-names>D</given-names></name><name name-style="western"><surname>Pirottin</surname><given-names>D</given-names></name><name name-style="western"><surname>Brouwers</surname><given-names>B</given-names></name><etal/></person-group>             <year>1997</year>             <article-title>A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle.</article-title>             <source>Nat Genet</source>             <volume>17</volume>             <fpage>71</fpage>             <lpage>74</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Mosher1">
        <label>5</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mosher</surname><given-names>DS</given-names></name><name name-style="western"><surname>Quignon</surname><given-names>P</given-names></name><name name-style="western"><surname>Bustamante</surname><given-names>CD</given-names></name><name name-style="western"><surname>Sutter</surname><given-names>NB</given-names></name><name name-style="western"><surname>Mellersh</surname><given-names>CS</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs.</article-title>             <source>PLoS Genet</source>             <volume>3</volume>             <fpage>e79</fpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Hill1">
        <label>6</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hill</surname><given-names>EW</given-names></name><name name-style="western"><surname>Gu</surname><given-names>J</given-names></name><name name-style="western"><surname>Eivers</surname><given-names>SS</given-names></name><name name-style="western"><surname>Fonseca</surname><given-names>RG</given-names></name><name name-style="western"><surname>McGivney</surname><given-names>BA</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>A sequence polymorphism in MSTN predicts sprinting ability and racing stamina in thoroughbred horses.</article-title>             <source>PLoS One</source>             <volume>5</volume>             <fpage>e8645</fpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Siriett1">
        <label>7</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Siriett</surname><given-names>V</given-names></name><name name-style="western"><surname>Platt</surname><given-names>L</given-names></name><name name-style="western"><surname>Salerno</surname><given-names>MS</given-names></name><name name-style="western"><surname>Ling</surname><given-names>N</given-names></name><name name-style="western"><surname>Kambadur</surname><given-names>R</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Prolonged absence of myostatin reduces sarcopenia.</article-title>             <source>J Cell Physiol</source>             <volume>209</volume>             <fpage>866</fpage>             <lpage>873</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Mendias1">
        <label>8</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mendias</surname><given-names>CL</given-names></name><name name-style="western"><surname>Bakhurin</surname><given-names>KI</given-names></name><name name-style="western"><surname>Faulkner</surname><given-names>JA</given-names></name></person-group>             <year>2008</year>             <article-title>Tendons of myostatin-deficient mice are small, brittle, and hypocellular.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>105</volume>             <fpage>388</fpage>             <lpage>393</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Schuelke1">
        <label>9</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Schuelke</surname><given-names>M</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>KR</given-names></name><name name-style="western"><surname>Stolz</surname><given-names>LE</given-names></name><name name-style="western"><surname>Hubner</surname><given-names>C</given-names></name><name name-style="western"><surname>Riebel</surname><given-names>T</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Myostatin mutation associated with gross muscle hypertrophy in a child.</article-title>             <source>N Engl J Med</source>             <volume>350</volume>             <fpage>2682</fpage>             <lpage>2688</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Wagner1">
        <label>10</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wagner</surname><given-names>KR</given-names></name><name name-style="western"><surname>Fleckenstein</surname><given-names>JL</given-names></name><name name-style="western"><surname>Amato</surname><given-names>AA</given-names></name><name name-style="western"><surname>Barohn</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Bushby</surname><given-names>K</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy.</article-title>             <source>Ann Neurol</source>             <volume>63</volume>             <fpage>561</fpage>             <lpage>571</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Fedoruk1">
        <label>11</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Fedoruk</surname><given-names>MN</given-names></name><name name-style="western"><surname>Rupert</surname><given-names>JL</given-names></name></person-group>             <year>2008</year>             <article-title>Myostatin inhibition: a potential performance enhancement strategy?</article-title>             <source>Scand J Med Sci Sports</source>             <volume>18</volume>             <fpage>123</fpage>             <lpage>131</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Ferrell1">
        <label>12</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ferrell</surname><given-names>RE</given-names></name><name name-style="western"><surname>Conte</surname><given-names>V</given-names></name><name name-style="western"><surname>Lawrence</surname><given-names>EC</given-names></name><name name-style="western"><surname>Roth</surname><given-names>SM</given-names></name><name name-style="western"><surname>Hagberg</surname><given-names>JM</given-names></name><etal/></person-group>             <year>1999</year>             <article-title>Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes.</article-title>             <source>Genomics</source>             <volume>62</volume>             <fpage>203</fpage>             <lpage>207</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Thomas1">
        <label>13</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>M</given-names></name><name name-style="western"><surname>Langley</surname><given-names>B</given-names></name><name name-style="western"><surname>Berry</surname><given-names>C</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>M</given-names></name><name name-style="western"><surname>Kirk</surname><given-names>S</given-names></name><etal/></person-group>             <year>2000</year>             <article-title>Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation.</article-title>             <source>J Biol Chem</source>             <volume>275</volume>             <fpage>40235</fpage>             <lpage>40243</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Rios1">
        <label>14</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Rios</surname><given-names>R</given-names></name><name name-style="western"><surname>Carneiro</surname><given-names>I</given-names></name><name name-style="western"><surname>Arce</surname><given-names>VM</given-names></name><name name-style="western"><surname>Devesa</surname><given-names>J</given-names></name></person-group>             <year>2002</year>             <article-title>Myostatin is an inhibitor of myogenic differentiation.</article-title>             <source>Am J Physiol Cell Physiol</source>             <volume>282</volume>             <fpage>C993</fpage>             <lpage>999</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Kostek1">
        <label>15</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kostek</surname><given-names>MA</given-names></name><name name-style="western"><surname>Angelopoulos</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Clarkson</surname><given-names>PM</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>PM</given-names></name><name name-style="western"><surname>Moyna</surname><given-names>NM</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Myostatin and follistatin polymorphisms interact with muscle phenotypes and ethnicity.</article-title>             <source>Med Sci Sports Exerc</source>             <volume>41</volume>             <fpage>1063</fpage>             <lpage>1071</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Corsi1">
        <label>16</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Corsi</surname><given-names>AM</given-names></name><name name-style="western"><surname>Ferrucci</surname><given-names>L</given-names></name><name name-style="western"><surname>Gozzini</surname><given-names>A</given-names></name><name name-style="western"><surname>Tanini</surname><given-names>A</given-names></name><name name-style="western"><surname>Brandi</surname><given-names>ML</given-names></name></person-group>             <year>2002</year>             <article-title>Myostatin polymorphisms and age-related sarcopenia in the Italian population.</article-title>             <source>J Am Geriatr Soc</source>             <volume>50</volume>             <fpage>1463</fpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Ivey1">
        <label>17</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ivey</surname><given-names>FM</given-names></name><name name-style="western"><surname>Roth</surname><given-names>SM</given-names></name><name name-style="western"><surname>Ferrell</surname><given-names>RE</given-names></name><name name-style="western"><surname>Tracy</surname><given-names>BL</given-names></name><name name-style="western"><surname>Lemmer</surname><given-names>JT</given-names></name><etal/></person-group>             <year>2000</year>             <article-title>Effects of age, gender, and myostatin genotype on the hypertrophic response to heavy resistance strength training.</article-title>             <source>J Gerontol A Biol Sci Med Sci</source>             <volume>55</volume>             <fpage>M641</fpage>             <lpage>648</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Seibert1">
        <label>18</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Seibert</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Xue</surname><given-names>QL</given-names></name><name name-style="western"><surname>Fried</surname><given-names>LP</given-names></name><name name-style="western"><surname>Walston</surname><given-names>JD</given-names></name></person-group>             <year>2001</year>             <article-title>Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the Women's Health and Aging Study II cohort.</article-title>             <source>J Am Geriatr Soc</source>             <volume>49</volume>             <fpage>1093</fpage>             <lpage>1096</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-GonzalezFreire1">
        <label>19</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Gonzalez-Freire</surname><given-names>M</given-names></name><name name-style="western"><surname>Rodriguez-Romo</surname><given-names>G</given-names></name><name name-style="western"><surname>Santiago</surname><given-names>C</given-names></name><name name-style="western"><surname>Bustamante-Ara</surname><given-names>N</given-names></name><name name-style="western"><surname>Yvert</surname><given-names>T</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>The K153R variant in the myostatin gene and sarcopenia at the end of the human lifespan.</article-title>             <source>Age (Dordr)</source>             <volume>32</volume>             <fpage>405</fpage>             <lpage>409</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Saunders1">
        <label>20</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Saunders</surname><given-names>MA</given-names></name><name name-style="western"><surname>Good</surname><given-names>JM</given-names></name><name name-style="western"><surname>Lawrence</surname><given-names>EC</given-names></name><name name-style="western"><surname>Ferrell</surname><given-names>RE</given-names></name><name name-style="western"><surname>Li</surname><given-names>WH</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Human adaptive evolution at Myostatin (GDF8), a regulator of muscle growth.</article-title>             <source>Am J Hum Genet</source>             <volume>79</volume>             <fpage>1089</fpage>             <lpage>1097</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Santiago1">
        <label>21</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Santiago</surname><given-names>C</given-names></name><name name-style="western"><surname>Rodriguez-Romo</surname><given-names>G</given-names></name><name name-style="western"><surname>Gomez-Gallego</surname><given-names>F</given-names></name><name name-style="western"><surname>Gonzalez-Freire</surname><given-names>M</given-names></name><name name-style="western"><surname>Yvert</surname><given-names>T</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Is there an association between ACTN3 R577X polymorphism and muscle power phenotypes in young, non-athletic adults?</article-title>             <source>Scand J Med Sci Sports</source>          </element-citation>
      </ref>
      <ref id="pone.0016323-Juffer1">
        <label>22</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Juffer</surname><given-names>P</given-names></name><name name-style="western"><surname>Furrer</surname><given-names>R</given-names></name><name name-style="western"><surname>Gonzalez-Freire</surname><given-names>M</given-names></name><name name-style="western"><surname>Santiago</surname><given-names>C</given-names></name><name name-style="western"><surname>Verde</surname><given-names>Z</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Genotype distributions in top-level soccer players: a role for ACE?</article-title>             <source>Int J Sports Med</source>             <volume>30</volume>             <fpage>387</fpage>             <lpage>392</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Young1">
        <label>23</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Young</surname><given-names>WB</given-names></name><name name-style="western"><surname>MacDonald</surname><given-names>C</given-names></name><name name-style="western"><surname>Flowers</surname><given-names>MA</given-names></name></person-group>             <year>2001</year>             <article-title>Validity of double- and single-leg vertical jumps as tests of leg extensor muscle function.</article-title>             <source>J Strength Cond Res</source>             <volume>15</volume>             <fpage>6</fpage>             <lpage>11</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Alcaraz1">
        <label>24</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Alcaraz</surname><given-names>PE</given-names></name><name name-style="western"><surname>Palao</surname><given-names>JM</given-names></name><name name-style="western"><surname>Elvira</surname><given-names>JL</given-names></name></person-group>             <year>2009</year>             <article-title>Determining the optimal load for resisted sprint training with sled towing.</article-title>             <source>J Strength Cond Res</source>             <volume>23</volume>             <fpage>480</fpage>             <lpage>485</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Nakagawa1">
        <label>25</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Nakagawa</surname><given-names>S</given-names></name><name name-style="western"><surname>Cuthill</surname><given-names>IC</given-names></name></person-group>             <year>2007</year>             <article-title>Effect size, confidence interval and statistical significance: a practical guide for biologists.</article-title>             <source>Biol Rev Camb Philos Soc</source>             <volume>82</volume>             <fpage>591</fpage>             <lpage>605</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Holm1">
        <label>26</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Holm</surname><given-names>S</given-names></name></person-group>             <year>1979</year>             <article-title>A simple sequentially rejective multiple test procedure.</article-title>             <source>Scand J Statist</source>             <volume>6</volume>             <fpage>65</fpage>             <lpage>70</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Yang1">
        <label>27</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>N</given-names></name><name name-style="western"><surname>MacArthur</surname><given-names>DG</given-names></name><name name-style="western"><surname>Gulbin</surname><given-names>JP</given-names></name><name name-style="western"><surname>Hahn</surname><given-names>AG</given-names></name><name name-style="western"><surname>Beggs</surname><given-names>AH</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>ACTN3 genotype is associated with human elite athletic performance.</article-title>             <source>Am J Hum Genet</source>             <volume>73</volume>             <fpage>627</fpage>             <lpage>631</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Ashley1">
        <label>28</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ashley</surname><given-names>CD</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>LW</given-names></name></person-group>             <year>1994</year>             <article-title>Vertical jump performance and selected physiological characteristics of women.</article-title>             <source>J Strength Cond Res</source>             <volume>8</volume>             <fpage>5</fpage>             <lpage>11</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Brown1">
        <label>29</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>LE</given-names></name><name name-style="western"><surname>Weir</surname><given-names>JP</given-names></name></person-group>             <year>2001</year>             <article-title>ASEP procedures recommendation I: Accurate assessment of muscular strength JEPonline JEP online</article-title>             <volume>4</volume>             <fpage>1</fpage>             <lpage>21</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Thomis1">
        <label>30</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Thomis</surname><given-names>MA</given-names></name><name name-style="western"><surname>Huygens</surname><given-names>W</given-names></name><name name-style="western"><surname>Heuninckx</surname><given-names>S</given-names></name><name name-style="western"><surname>Chagnon</surname><given-names>M</given-names></name><name name-style="western"><surname>Maes</surname><given-names>HH</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/deletion genotype in responses of human muscle to strength training.</article-title>             <source>Eur J Appl Physiol</source>             <volume>92</volume>             <fpage>267</fpage>             <lpage>274</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Bosco1">
        <label>31</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bosco</surname><given-names>C</given-names></name><name name-style="western"><surname>Mognoni</surname><given-names>P</given-names></name><name name-style="western"><surname>Luhtanen</surname><given-names>P</given-names></name></person-group>             <year>1983</year>             <article-title>Relationship between isokinetic performance and ballistic movement.</article-title>             <source>Eur J Appl Physiol Occup Physiol</source>             <volume>51</volume>             <fpage>357</fpage>             <lpage>364</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-PerezGomez1">
        <label>32</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Perez-Gomez</surname><given-names>J</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>GV</given-names></name><name name-style="western"><surname>Ara</surname><given-names>I</given-names></name><name name-style="western"><surname>Olmedillas</surname><given-names>H</given-names></name><name name-style="western"><surname>Chavarren</surname><given-names>J</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Role of muscle mass on sprint performance: gender differences?</article-title>             <source>Eur J Appl Physiol</source>             <volume>102</volume>             <fpage>685</fpage>             <lpage>694</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Ham1">
        <label>33</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ham</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Knez</surname><given-names>WL</given-names></name><name name-style="western"><surname>Young</surname><given-names>WB</given-names></name></person-group>             <year>2007</year>             <article-title>A deterministic model of the vertical jump: implications for training.</article-title>             <source>J Strength Cond Res</source>             <volume>21</volume>             <fpage>967</fpage>             <lpage>972</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Kubo1">
        <label>34</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kubo</surname><given-names>K</given-names></name><name name-style="western"><surname>Kawakami</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fukunaga</surname><given-names>T</given-names></name></person-group>             <year>1999</year>             <article-title>Influence of elastic properties of tendon structures on jump performance in humans.</article-title>             <source>J Appl Physiol</source>             <volume>87</volume>             <fpage>2090</fpage>             <lpage>2096</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Cavagna1">
        <label>35</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Cavagna</surname><given-names>GA</given-names></name></person-group>             <year>1977</year>             <article-title>Storage and utilization of elastic energy in skeletal muscle.</article-title>             <source>Exerc Sport Sci Rev</source>             <volume>5</volume>             <fpage>89</fpage>             <lpage>129</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Lee1">
        <label>36</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>SJ</given-names></name><name name-style="western"><surname>McPherron</surname><given-names>AC</given-names></name></person-group>             <year>2001</year>             <article-title>Regulation of myostatin activity and muscle growth.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>98</volume>             <fpage>9306</fpage>             <lpage>9311</lpage>          </element-citation>
      </ref>
      <ref id="pone.0016323-Jiang1">
        <label>37</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>MS</given-names></name><name name-style="western"><surname>Liang</surname><given-names>LF</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Ratovitski</surname><given-names>T</given-names></name><name name-style="western"><surname>Holmstrom</surname><given-names>J</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Characterization and identification of the inhibitory domain of GDF-8 propeptide.</article-title>             <source>Biochem Biophys Res Commun</source>             <volume>315</volume>             <fpage>525</fpage>             <lpage>531</lpage>          </element-citation>
      </ref>
    </ref-list>
    
  </back>
</article>